Hva betyr "Tøm"?
Dyret bærer ikke mutasjonen. Det vil ikke utvikle sykdommen og vil ikke gi det videre.
Hund Australian Labradoodle Dystrofinopati (DMD-AL)
Discover the Australian Labradoodle Dystrophinopathy (DMD-AL) DNA test, an essential tool for dog breeders and owners. This genetic test identifies the presence of mutations linked to DMD-AL, a condition affecting muscle strength and health in Australian Labradoodles. Early detection through DMD-AL testing can help prevent the onset of symptoms and guide responsible breeding practices. Ensure your furry friend’s well-being by opting for this crucial DNA test. By understanding your dog’s genetic profile, you can make informed decisions that promote a healthier, happier life. Trust the DMD-AL DNA test for a proactive approach to your Australian Labradoodle's health. Take action today to safeguard your pet's future!
Forkortelse: DMD-AL
Analysert mutasjon: DMD c.2668C>T
Arv: X-linked recessiv
Akronym
DMD-AL
Observert frekvens
Klinisk alvorlighetsgrad
Klinisk klassifisering
Muskelsykdommer
Analysert mutasjon
DMD c.2668C>T
p.(R890*)
p.(R890*)
Metode for arv
X-linked recessiv
Alternativt navn:
Duchenne Muscular Dystrophy In Australian Labradoodle
Testsammendrag:
The Australian Labradoodle Dystrophinopathy (DMD-AL) is a genetic condition affecting Australian Labradoodles, characterized by a deficiency in dystrophin, a protein essential for muscle function. This DNA test helps identify carriers of the mutation responsible for the disease, allowing breeders to make informed decisions and reduce its prevalence. Early detection through genetic testing can lead to better management strategies and ensure healthier breeding practices. Responsible breeding can significantly improve the quality of life for affected dogs, promoting overall breed health. Owners and breeders are encouraged to utilize this test to support the wellbeing of future generations of Australian Labradoodles.
Tilgjengelig fra pakken: Basic
Denne DNA-testen er inkludert fra pakken vår Basic — og er også en del av pakkene Basic, Standard, Advanced, Complete.
Se DNA-testpakker →Velg pakken som passer best til din avl eller helsestrategi for dyrene dine.
Understanding Australian Labradoodle Dystrophinopathy (DMD-AL)
Australian Labradoodle Dystrophinopathy (DMD-AL) is a genetic condition that affects the muscle function of Australian Labradoodles. This disorder is caused by mutations in the dystrophin gene, which is essential for maintaining the integrity of muscle fibers. As a result, affected dogs may experience progressive muscle weakness and degeneration, leading to significant mobility issues over time.
Symptoms of DMD-AL
Dogs with DMD-AL often exhibit a range of symptoms that can vary in severity. Common signs include difficulty in walking, reluctance to engage in physical activities, and noticeable muscle wasting. As the disease progresses, owners may observe a decline in the dog’s overall stamina and strength, which can severely impact their quality of life.
Diagnosis of DMD-AL
Diagnosis of DMD-AL typically involves a combination of clinical evaluation and genetic testing. Veterinarians may conduct physical examinations to assess muscle strength and function. Additionally, DNA testing can confirm the presence of the specific mutations associated with DMD-AL, providing a definitive diagnosis.
Viktigheten av DNA-testing
DNA testing for DMD-AL is crucial for breeders and dog owners alike. For breeders, it helps in making informed decisions to avoid producing affected puppies, thus contributing to the overall health of the breed. For owners, knowing whether their dog is a carrier or affected allows for better management of the condition and planning for future care needs.
Management of DMD-AL
Currently, there is no cure for DMD-AL, but management strategies can help improve the quality of life for affected dogs. This may include physical therapy, nutritional support, and regular veterinary check-ups to monitor the progression of the disease. Owners should work closely with their veterinarians to develop a tailored management plan that addresses the specific needs of their dog.
Konklusjon
Understanding Australian Labradoodle Dystrophinopathy (DMD-AL) is essential for responsible dog ownership and breeding practices. DNA testing plays a vital role in identifying affected and carrier dogs, enabling proactive measures to promote the health and well-being of this beloved breed. Awareness and education about DMD-AL can significantly enhance the lives of both dogs and their owners.
Rase anerkjent for testen: Australian Labradoodle Dystrofinopati (DMD-AL)
- Labradoodle
🧬 Interpretation of genotypes DMD-AL
Genotype
Status
🟡 N/N
Ikke-transportør - Ingen risiko
❌ ♂ N/DMD-AL
Berørt - i faresonen
🟡 ♀ N/DMD-AL
Transportør - Ingen risiko
❌ DMD-AL/DMD-AL
Berørt - i faresonen
FAQ: forstå tolkningen
Er en "Carrier" seriøs?
Nei. Dyret er generelt sunt, men kan overføre mutasjonen til dens avkom.
Hva om et dyr er "påvirket"?
Den har to muterte kopier. Kliniske tegn forventes avhengig av sykdommen. Det skal ikke avles.
Hvorfor er det forskjeller mellom mann og kvinne?
Noen sykdommer er kjønnsbundne, så uttrykket deres varierer avhengig av dyrs kjønn.
Forutsi avkom
N/N (ikke-transportor)
N/DMD-AL (Transportør)
DMD-AL/DMD-AL (Berørt)
Vanlige spørsmål om DNA-test
Hva oppdager denne DNA-testen?
This DNA test detects the mutation associated with Australian Labradoodle Dystrophinopathy (DMD) in order to identify clear, carrier, or at-risk animals.
Hvorfor teste et avlsdyr?
DNA-testing hjelper oppdrettere med å planlegge sikrere parringer og redusere risikoen for å overføre mutasjonen til avkom.
Hva er arvemodusen for denne testen?
Arvemodusen som er rapportert for denne testen er X-Linked Recessive.
Hvilken mutasjon analyseres i denne testen?
This test analyses the mutation DMD c.2668C>T.
Er et bærerdyr nødvendigvis påvirket?
Ikke nødvendigvis. Tolkning avhenger av arvemønsteret og den resulterende genotypen.
Referanser
Shrader Stephanie M, Jung SeungWoo, Denney Thomas S, Smith Bruce F. Characterization of Australian Labradoodle dystrophinopathy. Neuromuscul Disord. 2018 Nov;28(11):927-937. doi: 10.1016/j.nmd.2018.08.008. Epub 2018 Aug 29.